Company page

Aktis Oncology, Inc.

Aktis Oncology, Inc. is a public company listed under the ticker AKTS, operating in the American market. The company has a market capitalization of approximately $1.38 billion. Aktis Oncology focuses on developing innovative cancer therapies to improve patient outcomes.

AKTS:NASDAQUpdated September 12, 2026
Aktis Oncology, Inc. logo
Ticker
AKTS:NASDAQ
Asset type
Stock
Market cap
$1.30B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD